Analysed ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) News Sources
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
06-10-2026
yahoo.com
Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer
08-10-2026
yahoo.com
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
13-10-2026
yahoo.com
AI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Million
21-10-2026
yahoo.com
New Canadian Real-World Evidence at ESMO 2026 Highlights Integration of CLDN18.2 Testing and Targeted Treatment in Clinical Practice
26-10-2026
yahoo.com
Astellas and Audax Biosciences Enter Exclusive Option and License Agreement for DAX-044, a Novel Immune-Targeted IL-12 Antibody-Cytokine Fusion for Immuno-Oncology
27-10-2026
yahoo.com
Astellas fortifies immuno-oncology pipeline on $1.3bn Audax licensing deal
28-10-2026
pharmaceutical-technology.com
Lilly shuffles business structure; Novartis writes off part of Avidity deal
28-10-2026
biopharmadive.com
What is the current price of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?
The current price of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is $16.16.
ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) since the previous trading day is $0.16.
ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) since the previous trading day is 1%.
What is the most recent average sentiment score for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?
The most recent average sentiment score for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is 79 out of 100.
What is the most recent average sentiment for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?
The most recent sentiment for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is .
SEC-8K** Filing Available For ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.